MTOR and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma (HNSCC), MAPK/ERK kinase (MEK)/ERK/activator protein 1 (AP-1), NF-κB and mTOR signaling pathways are frequently activated.